Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Title:||2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS|
Van Putte, B.
Baron Esquivias, G.
|Citation:||European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2016; 50(5):e1-e88|
|Publisher:||Oxford University Press|
|Paulus Kirchhof, Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar ... Jeroen Hendriks ... et al.|
|Abstract:||Guidelines summarize and evaluate all available evidence on a particular issue at the time of the writing process, with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition, taking into account the impact on outcome, as well as the risk–benefit ratio of particular diagnostic or therapeutic means. Guidelines and recommendations should help health professionals to make decisions in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of Guidelines have been issued in recent years by the European Society of Cardiology (ESC) and by the European Association for Cardio-Thoracic Surgery (EACTS), as well as by other societies and organisations. Because of the impact on clinical practice, quality criteria for the development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC website (http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Guidelines-development/Writing-ESC-Guidelines). ESC Guidelines represent the official position of the ESC on a given topic and are regularly updated. Members of this Task Force were selected by the ESC, including representation from the European Heart Rhythm Association (EHRA), and EACTS as well as by the European Stroke Organisation (ESO) to represent professionals involved with the medical care of patients with this pathology. Selected experts in the field undertook a comprehensive review of the published evidence for management (including diagnosis, treatment, prevention and rehabilitation) of a given condition according to ESC Committee for Practice Guidelines (CPG) policy and approved by the EACTS and ESO. A critical evaluation of diagnostic and therapeutic procedures was performed, including assessment of the risk–benefit ratio. Estimates of expected health outcomes for larger populations were included, where data exist. The level of evidence and the strength of the recommendation of particular management options were weighed and graded according to predefined scales, as outlined in Tables 1 and 2.|
|Keywords:||Guidelines; atrial fibrillation; anticoagulation; vitamin K antagonists; non-vitamin K antagonist oral anticoagulants; left atrial appendage occlusion; rate control; cardioversion; rhythm control; antiarrhythmic drugs; upstream therapy; catheter ablation; AF surgery; valve repair; pulmonary vein isolation; left atrial ablation|
|Rights:||© The European Society of Cardiology 2016. Reproduced with kind permission.|
|Appears in Collections:||Medicine publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.